1. A 22-year-old woman presents with a "pimple" on her B. a hordeolum
right eyelid. Examination reveals a 2-mm pustule on
the lateral border of the right eyelid margin. This is
most consistent with:
A. a chalazion
B. a hordeolum
C. blepharitis
D. cellulitis
2. Treatment options for uncomplicated hordeolum in- D. oral antimicrobial thera-
clude all of the following except: py
A. erythromycin ophthalmic ointment
B. warm compresses to the affected area
C. incision and drainage
D. oral antimicrobial therapy
3. When advising a patient with scarlet fever, the NP con- B. the rash often peels
siders that: during recovery
A. there is increased risk for poststreptococcal
glomerulonephritis
B. the rash often peels during recovery
C. an injectable cephalosporin is the preferred treat-
ment option
D. throat culture is usually negative for group A strep-
tococci
4. The incubation period for M. pneumoniae is usually: D. 3 weeks
A. less than 1 week
B. 1 week
C. 2 weeks
D. 3 weeks
, Nur676
5. The incubation period for S. pyogenes is usually: B. 3 to 5 days
A. 1 to 3 days
B. 3 to 5 days
C. 6 to 9 days
D. 10 to 13 days
6. All of the following are common causes of penicillin A. infection with a
treatment failure in streptococcal pharyngitis except: beta-lactamase producing
A. infection with a beta-lactamase producing Strepto- Streptococcus strain
coccus strain
B. failure to initiate or complete the antimicrobial
course
C. concomitant infection or carriage with a beta-lacta-
mase-producing organism
D. inadequate penicillin dosage
7. Oral decongestant use should be discouraged in pa- C. cardiovascular disease
tients with:
A. allergic rhinitis
B. migraine headache
C. cardiovascular disease
D. chronic bronchitis
8. In the treatment of allergic rhinitis, leukotriene modi- B. an inflammatory in-
fiers should be used as: hibitor
A. an agent to relieve nasal itch
B. an inflammatory inhibitor
C. a rescue drug
D. an intervention in acute inflammation
9. Cromolyn's mechanism of action is as a/an: C. mast cell stabilizer
A. anti-immunoglobulin E antibody
B. vasoconstrictor
, Nur676
C. mast cell stabilizer
D. leukotriene modifier
10. Therapeutic interventions for the patient in Question 1 A. systemic corticosteroid
(giant cell arteritis), should include: therapy for many months
A. systemic corticosteroid therapy for many months
B. addition of an angiotensin-converting enzyme in-
hibitor (ACEI) to her antihypertensive regimen
C. warfarin therapy
D. initiation of topirimate (Topamax)
11. A 74 year-old woman with well-controlled hyperten- A. giant cell arteritis
sion who is taking hydrochlorothiazide presents with
a 3-day history of unilateral throbbing headache with
difficulty chewing because of the pain. On physical
examination, you find a tender, noncompressible tem-
poral artery. Blood pressure (BP) is 160/88 mm Hg,
apical pulse is 98 bpm, and respiratory rate is 22/min;
the patient is visibly uncomfortable. The most likely
diagnosis is:
A. giant cell arteritis
B. impending transient ischemic attack
C. complicated migraine
D. temporal mandibular joint dysfunction
12. One of the most serious complications of giant cell C. blindness
arteritis is:
A. hemiparesis
B. arthritis
C. blindness
D. uveitis
13.